| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-09-28 17:40 Tx date 2022-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+43,750 vol |
80,148 | |
| Filed 2022-09-28 17:39 Tx date 2022-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+21,875 vol |
91,485 | |
| Filed 2022-03-09 11:32 Tx date 2022-01-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+9,995 vol |
69,610 | |
| Filed 2021-10-05 15:53 Tx date 2021-10-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,539 vol |
59,615 | |
| Filed 2021-10-05 15:52 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV, L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$175,290
+54,438 vol $3.22 each |
128,607 | |
| Filed 2021-10-05 15:51 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Capital IV (International) L.P. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,710
+1,463 vol $3.22 each |
3,456 | |
| Filed 2021-09-21 16:17 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 16:16 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 09:00 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
36,398 | |
| Filed 2021-09-21 09:00 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+26,318 vol |
||
| Filed 2021-09-21 08:57 Tx date 2021-09-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+13,159 vol |
51,076 | |
| Filed 2021-07-07 08:29 Tx date 2021-07-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$25,176
+3,536 vol $7.12 each |
37,917 | |
| Filed 2021-04-27 16:26 Tx date 2021-04-22 |
$EDSA
Edesa Biotech, Inc. |
van der Velden, Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
51,389 | |
| Filed 2021-04-05 10:55 Tx date 2021-04-01 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+3,195 vol |
34,381 | |
| Filed 2021-02-25 11:51 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$65,018
+9,661 vol $6.73 each |
9,661 | |
| Filed 2021-02-25 11:51 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-25 11:50 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+4,830 vol |
4,830 | |
| Filed 2021-02-25 11:49 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III (International), L.P. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-25 11:49 Tx date 2021-02-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+145,170 vol |
145,170 | |
| Filed 2021-02-25 11:47 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
van der Velden, Peter
4 - Director of Issuer
Holder: Lumira Ventures III, L.P. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|